FutureGen Funding: $59M Raised, Series B (2020)

FutureGen is based in Beijing, China. It has raised $59M in total funding. Latest round: Series B. Backed by CICC Capital, DYEE Capital, MSA Capital.

FutureGen funding overview

FutureGen is based in Beijing, China. FutureGen has raised $59M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series B announced in January 2020. The round record for FutureGen runs through 2020; nothing later has been disclosed. Investors on record include CICC Capital, DYEE Capital, MSA Capital, Sinopharm Capital, LAV (Lilly Asia Fund). 5 distinct backers are named across the disclosed rounds.

FutureGen at a glance

Total raised
$59M
Latest round
Series B
Latest round date
January 2020
Headquarters
Beijing, China
Notable investors
CICC Capital, DYEE Capital, MSA Capital, Sinopharm Capital, LAV (Lilly Asia Fund)

Frequently asked about FutureGen funding

How much has FutureGen raised?
FutureGen has raised $59M in total disclosed funding across the rounds on record.
Who has invested in FutureGen?
CICC Capital, DYEE Capital, MSA Capital, Sinopharm Capital, LAV (Lilly Asia Fund) are named among the investors backing FutureGen.
What was the latest FutureGen funding round?
The most recent disclosed round is a Series B, announced in January 2020.
Where is FutureGen based?
FutureGen is based in Beijing, China.
When did FutureGen last raise?
The last disclosed FutureGen round closed in January 2020 at Series B.

FutureGen totals reflect disclosed capital only — undisclosed extensions and secondaries are excluded. Use the related companies in Beijing below to benchmark round size and investor mix.

Companies related to FutureGen (36)

Browse related funding lists (6)

Company funding database · Investor directory · Founder database · Mega-rounds 2026